NeuroBo Pharmaceuticals, Inc. Quarterly Return On Assets in % from Q1 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
NeuroBo Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2017 to Q3 2024.
  • NeuroBo Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -122 %, a 212% decline year-over-year.
  • NeuroBo Pharmaceuticals, Inc. annual Return On Assets for 2023 was -45.4 %, a 47.5% increase from 2022.
  • NeuroBo Pharmaceuticals, Inc. annual Return On Assets for 2022 was -86.4 %, a 29.7% increase from 2021.
  • NeuroBo Pharmaceuticals, Inc. annual Return On Assets for 2021 was -123 %, a 47% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -122 -83.1 -212% Jul 1, 2024 Sep 30, 2024
Q2 2024 -109 -65.3 -149% Apr 1, 2024 Jun 30, 2024
Q1 2024 -69.5 -3.24 -4.89% Jan 1, 2024 Mar 31, 2024
Q4 2023 -45.4 +41 +47.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -39.2 +76.6 +66.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -43.7 +73.7 +62.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -66.3 +54.7 +45.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -86.4 +36.4 +29.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -116 +159 +57.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -117 +126 +51.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -121 +88.9 +42.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -123 +109 +47% Oct 1, 2021 Dec 31, 2021
Q3 2021 -275 -104 -60.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -243 -22.4 -10.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -210 +84.2 +28.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -232 +87.8 +27.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -172 +119 +40.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -221 -75.6 -52.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 -294 -176 -148% Jan 1, 2020 Mar 31, 2020
Q4 2019 -319 -217 -212% Oct 1, 2019 Dec 31, 2019
Q3 2019 -290 -191 -192% Jul 1, 2019 Sep 30, 2019
Q2 2019 -145 -37.4 -34.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -119 +10 +7.78% Jan 1, 2019 Mar 31, 2019
Q4 2018 -102 +33.9 +24.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -99.4 +31.1 +23.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -108 +1.51 +1.38% Apr 1, 2018 Jun 30, 2018
Q1 2018 -129 -40.1 -45.2% Jan 1, 2018 Mar 31, 2018
Q4 2017 -136 Oct 1, 2017 Dec 31, 2017
Q3 2017 -131 Jul 1, 2017 Sep 30, 2017
Q2 2017 -109 Apr 1, 2017 Jun 30, 2017
Q1 2017 -88.6 Jan 1, 2017 Mar 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.